Literature DB >> 34826745

Advances in the therapeutic delivery and applications of functionalized Pluronics: A critical review.

Pankaj Singla1, Saweta Garg2, Jake McClements1, Oliver Jamieson1, Marloes Peeters3, Rakesh Kumar Mahajan4.   

Abstract

Pluronic (PEO-PPO-PEO) block copolymers can form nano-sized micelles with a structure composed of a hydrophobic PPO core and hydrophilic PEO shell layer. Pluronics are U.S. Food and Drug Administration approved polymers, which are widely used for solubilization of drugs and their delivery, gene/therapeutic delivery, diagnostics, and tissue engineering applications due to their non-ionic properties, non-toxicity, micelle forming ability, excellent biocompatibility and biodegradability. Although Pluronics have been employed as drug carrier systems for several decades, numerous issues such as rapid dissolution, shorter residence time in biological media, fast clearance and weak mechanical strength have hindered their efficacy. Pluronics have been functionalized with pH-sensitive, biological-responsive moieties, antibodies, aptamers, folic acid, drugs, different nanoparticles, and photo/thermo-responsive hydrogels. These functionalization strategies enable Pluronics to act as stimuli responsive and targeted drug delivery vehicles. Moreover, Pluronics have emerged in nano-emulsion formulations and have been utilized to improve the properties of cubosomes, dendrimers and nano-sheets, including their biocompatibility and aqueous solubility. Functionalization of Pluronics results in the significant improvement of target specificity, loading capacity, biocompatibility of nanoparticles and stimuli responsive hydrogels for the promising delivery of a range of drugs. Therefore, this review presents an overview of all advancements (from the last 15 years) in functionalized Pluronics, providing a valuable tool for industry and academia in order to optimize their use in drug or therapeutic delivery, in addition to several other biomedical applications.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibody; Aptamers; Drug delivery; Functionalized pluronics; Hydrogels; Nanoparticles; Nanosheets; Theranostics

Mesh:

Substances:

Year:  2021        PMID: 34826745     DOI: 10.1016/j.cis.2021.102563

Source DB:  PubMed          Journal:  Adv Colloid Interface Sci        ISSN: 0001-8686            Impact factor:   12.984


  2 in total

1.  Poloxamer-linked prodrug of a topoisomerase I inhibitor SN22 shows efficacy in models of high-risk neuroblastoma with primary and acquired chemoresistance.

Authors:  Ivan S Alferiev; David T Guerrero; Peng Guan; Ferro Nguyen; Venkatadri Kolla; Danielle Soberman; Benjamin B Pressly; Ilia Fishbein; Garrett M Brodeur; Michael Chorny
Journal:  FASEB J       Date:  2022-03       Impact factor: 5.834

2.  Melting Point Depression of Poly(ethylene oxide)-Poly(propylene oxide)-Poly(ethylene oxide) Triblock Polymers in Supercritical Carbon Dioxide in the Presence of Menthol as a Solid Co-Plasticiser.

Authors:  Vivek Trivedi; Adejumoke Lara Ajiboye; Nichola J Coleman; Ruchir Bhomia; Marion Bascougnano
Journal:  Polymers (Basel)       Date:  2022-07-11       Impact factor: 4.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.